Name: Zhengye Biotechnology Holding Limited (ZYBT) Balance Sheet
Creator: FinSpry

Zhengye Biotechnology Holding Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions CNY

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Zhengye Biotechnology Holding Limited (ZYBT) - Annual data in millions CNY
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	18.60	15.07	9.75	6.28
Short-Term Investments	1.43	1.22	0.00	0.00
Cash & Short-Term Investments	20.04	16.30	9.75	6.28
Accounts Receivable	59.56	99.42	134.25	102.19
Inventory	58.22	58.30	55.42	43.62
Other Current Assets	10.79	0.00	0.00	0.00
Total Current Assets	177.57	189.24	214.31	164.94
Non-Current Assets
Property, Plant & Equipment (Net)	255.16	263.25	275.23	246.41
Intangible Assets	22.78	24.48	27.90	20.75
Other Non-Current Assets	26.75	6.50	2.23	13.17
Total Non-Current Assets	315.68	310.65	305.37	280.34
Total Assets	493.25	499.89	519.67	445.28
Current Liabilities
Accounts Payable	42.96	45.66	79.28	77.57
Short-Term Debt	81.63	79.86	54.89	30.00
Current Portion of Long-Term Debt	7.19	0.00	0.00	0.00
Accrued Liabilities	0.10	0.54	0.57	0.60
Deferred Revenue	3.69	3.99	4.70	4.28
Other Current Liabilities	0.56	17.90	2.79	6.37
Total Current Liabilities	135.91	150.23	152.23	125.63
Non-Current Liabilities
Long-Term Debt	4.80	9.99	9.99	0.00
Other Non-Current Liabilities	0.00	0.39	0.59	0.82
Total Non-Current Liabilities	4.80	10.38	10.58	0.82
Total Liabilities	140.71	160.62	162.81	126.44
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01
Retained Earnings	48.15	69.69	93.34	64.32
Accumulated Other Comprehensive Income	32.65	31.31	27.57	21.99
Additional Paid-in Capital	203.15	203.15	203.15	203.15
Minority Interest	68.58	66.42	60.37	51.36
Shares Outstanding	47.17	47.17	47.17	47.17
Total Stockholders' Equity	283.96	339.27	356.87	318.84
Total Liabilities & Equity	493.25	499.89	519.67	445.28